高级检索

大黄酸的HPLC-荧光检测及其在人体药代动力学中的应用

Determination of rhein in plasma,urine and feces by HPLC-fluorescence detection and its pharmacokinetics in healthy volunteers

  • 摘要: 建立大黄酸在健康志愿者血浆及尿粪中的HPLC-荧光检测方法(HPLC-FLD),色谱柱为Hypersil C18(25 cm×4.6 mm,2.5 μm),流动相为甲醇-乙腈-1%冰醋酸(61∶15∶24),柱温为40 ℃,内标为1,8-二羟基蒽醌,检测激发波长为440 nm,发射波长为520 nm。在所建立的色谱条件下,大黄酸与各杂质分离良好,在血浆、尿、粪中线性范围分别为0.05~10.00 μg/mL,0.10~25.00 μg/mL,0.20~100.00 μg/mL,最低定量限分别为0.05,0.10 和0.20 μg/mL。健康受试者单次口服200 mg 大黄酸后,血药浓度-时间曲线呈二房室模型。主要药代动力学参数cmax,tmax,AUC0-∞,t1/2以及MRT分别为(16.0±3.4) μg/mL,(4.0±0.6) h,(152.7±45.7) μg·h/mL,(5.5±1.1) h以及 (8.9±2.2) h;原药大黄酸在尿、粪中累积排泄分数分别为(8.19±1.84)%和11.00%。该法操作简便、灵敏,适用于对微量生物样品进行大批量测定。

     

    Abstract: This study established a HPLC-fluorescence detection(HPLC-FLD) assay for determining of rhein in human plasma,urine and feces on a reversed-phase C18 column with a mobile phase of methanol-acetonitrile-1% acetic acid (61 ∶15 ∶24).HPLC-FLD was performed at excitation wavelength 440 nm and emission wavelength 520 nm for rhein and the internal standard.Calibration curves were linear over the ranges of 0.05-10.00 μg/mL in plasma,0.10-25.00 μg/mL in urine and 0.20-100.00 μg/mL in feces.The lowest limit of quantification for rhein was 0.05 μg/mL in plasma,0.10 μg/mL in urine and 0.20 μg/mL in feces.The recovery of this method was greater than 80%.The main pharmacokinetic parameters cmax,tmax,AUC0-∞,t1/2 and MRT were (16.0±3.4) μg/mL,(4.0±0.6) h,(152.7±45.7) μg ·h/mL,(5.5±1.1) h and (8.9±2.2) h,respectively.The accumulative excretion rate of rhein in urine and feces were (8.19±1.84)% and 11.00%,separately.This assay was proved to be convenient,accurate,sensitive and suitable for mass determination of biological samples.

     

/

返回文章
返回